Kevin Bitterman Profile
Kevin Bitterman

@KevinBitterman

Followers
627
Following
254
Statuses
54

Joined October 2011
Don't wanna be here? Send us removal request.
@KevinBitterman
Kevin Bitterman
10 months
RT @atlasventure: Congratulations to the team @MarianaOncology on their acquisition by Novartis for $1B upfront! Having co-founded, seeded,…
0
2
0
@KevinBitterman
Kevin Bitterman
10 months
RT @SimonRead0: Big day today at Mariana Oncology! My sincere thanks to all my colleagues, board members and investors who made the company…
0
10
0
@KevinBitterman
Kevin Bitterman
2 years
RT @DiscMedicine: In data presented at #EHA2023, Disc announced initial positive results from BEACON, our Phase 2 clinical trial for bitope…
0
3
0
@KevinBitterman
Kevin Bitterman
2 years
RT @atlasventure: We are so pleased to announce that Jeff Albers has joined Atlas as a Venture Partner! We look forward to working closely…
0
1
0
@KevinBitterman
Kevin Bitterman
2 years
RT @DiscMedicine: Today we announced Disc has completed its merger with Gemini Therapeutics. The combined company, advancing Disc’s pipelin…
0
2
0
@KevinBitterman
Kevin Bitterman
2 years
RT @LifeSciVC: Takeda Acquires Nimbus’ Tyk2 Autoimmune Program for up to $6B Congrats to @JebKeiper & the @NimbusTx team! Here's a blog…
0
28
0
@KevinBitterman
Kevin Bitterman
2 years
RT @chromamedicine: Chroma welcomes @JeffMarrazzo, founding CEO of Spark Therapeutics to our Board – Jeff’s pioneering contributions to #Ge
0
6
0
@KevinBitterman
Kevin Bitterman
2 years
RT @LifeSciVC: Another Reach the Beach in the record books! #RTB2022
Tweet media one
0
2
0
@KevinBitterman
Kevin Bitterman
3 years
@michael_gilman Real question is what is the ratio of Dead to JGB versions?
0
0
0
@KevinBitterman
Kevin Bitterman
3 years
RT @atlasventure: We are thrilled to continue working alongside talented entrepreneurs to build breakthrough biotech startups via our new $…
0
24
0
@KevinBitterman
Kevin Bitterman
3 years
RT @chromamedicine: We are excited to introduce Chroma Medicine, a genomic medicine company pioneering epigenetic editing to precisely regu…
0
22
0
@KevinBitterman
Kevin Bitterman
3 years
RT @atlasventure: We are proud to announce Atlas Venture Opportunity Fund II, a $300M fund dedicated to supporting our breakthrough portfol…
0
16
0
@KevinBitterman
Kevin Bitterman
4 years
RT @ProjectOnramp: VC firm @atlasventure will welcome their first-ever marketing intern this summer thanks to support from Kristen Margeson…
0
5
0
@KevinBitterman
Kevin Bitterman
4 years
RT @atlasventure: We are excited to welcome @SamTruex to the Atlas team today!
Tweet media one
0
5
0
@KevinBitterman
Kevin Bitterman
4 years
@JasonPaulRhodes @atlasventure My effort. The stracciatella di bufala was key
Tweet media one
0
0
2
@KevinBitterman
Kevin Bitterman
4 years
RT @RemixThera: Exciting news! Matthew Patterson has joined Remix as Executive Chair!
Tweet media one
0
3
0
@KevinBitterman
Kevin Bitterman
4 years
@AlexHarding7 @VedereBio Thanks Alex! You were far more than just along for the ride and appreciate all the work you did to help the company get to this outcome.
0
0
2
@KevinBitterman
Kevin Bitterman
4 years
We couldn’t be more thrilled to see Novartis advance this technology.
@jaybradner
Jay Bradner, M.D.
4 years
Pleased to share that we’re adding @VedereBio’s #optogenetics-based gene therapy tech to our arsenal to bring next-generation gene therapy to an even broader population of patients with blindness
Tweet media one
1
0
8
@KevinBitterman
Kevin Bitterman
4 years
RT @atlasventure: Congratulations @VedereBio!
0
1
0
@KevinBitterman
Kevin Bitterman
5 years
RT @LifeSciVC: "Leave a Ladder Down, Part Deux" - @SamTruex opines on the importance of helping and mentoring others to access career paths…
0
9
0